Download Medical Notes on Evaluate Vantage Report on impact of COVID-19 Biopharma and Medtech

Evaluate Vantage Report on impact of COVID-19 Biopharma and Medtech Medical Notes

About This Presentation

Description:Biopharma and Medtech are certainly leading the fight against coronavirus COVID-19. However, they are certainly not immune from the adverse economic impact of the pandemic. We are witnessing a devastating effect of the coronavirus COVID-19 pandemic on global health and economies. And as expected, the biopharma and medtech sectors are under tremendous pressure to come up with solutions to relieve the humanity at record speed. This Evaluate Vantage COVID-19 Report throws light on the progress so far, to deduce which treatments and vaccines are expected to deliver in the fight against the virus. The report also discusses the wider effect the global pandemic is having on the biopharma and medtech sector. This includes share price declines, the potential financial implications, the cost of delays, deals being triggered by the pandemic, Biopharma and medtech’s response, the impact on biophar

Tags:EvaluatePharma, pharmaceutical industry, pharma, pharmaceutical, financial markets, R&D, Biopharma, Medtech, coronavirus, COVID-19, pandemic, vaccines

Published on: Jun 29, 2020 | Views : 957 | Downloads : 0

Comment

Transcript

No transcript available for this presentation

User Presentation
Related Presentations

United Nations Office on Drugs and Crime (UNODC) World Drug Report 2019 - Booklet 4

About : An experienced pharma professional managing sales, marketing and brand management of top global pharma products Presently leading a team of experts in the development and execution of pharma eCommerce strategies that support GSK products to HCP customers.
Occupation : Medical Professional
Specialty : Other Health Professionals
Country : United States of America
Website :

United Nations Office on Drugs and Crime (UNODC) World Drug Report 2019 - Booklet 4

United Nations Office on Drugs and Crime (UNODC) World Drug Report 2020 - Booklet 4.1

High-Performance Pharma Brand Plans - The 5 Pitfalls to avoid

EvaluatePharma Orphan Drug Report 2020

Evaluate Vantage Pharma, Biotech & Medtech 2019 in Review

Evaluate Vantage Pharma, Biotech & Medtech 2019 in Review

The Indian pharmaceutical industry - The Journey until Now and the Way Forward

Evaluate Vantage Pharma, Biotech and Medtech Half-Year Review 2020

2019 R&D Achievements New product launches, clinical trial activity, and investments

Coronavirus COVID-19 response for Pharma companies

HEALTH A TO Z